Effect of different UCOE-promoter combinations in creation of engineered cell lines for the production of Factor VIII

BMC Research Notes

Volumn 4, Issue , 2011, Pages

  Nair, Ayyappan R ^a   Jinger, Xie ^a   Hermiston, Terry W ^a  

^a Bayer Healthcare   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN HERPESVIRUS 5; MAMMALIA;

EID: 79958156431     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-4-178     Document Type: Article

References (16)

1. DNA methylation and histone modidications: teaming up to silence genes. F Fuks, Current opinion in genetics and development 2005 15 490 495 10.1016/j.gde.2005.08.002 16098738 (Pubitemid 41262404)
2. CpG methylation, chromatin structure and gene silencing - a three-way connection. A Razin, EMBO 1998 17 4905 4908 10.1093/emboj/17.17.4905 (Pubitemid 28408457)
3. Methylation-induced repression - belts, braces, and chromatin. AP Bird AP Wolffe, Cell 1999 99 451 454 10.1016/S0092-8674(00)81532-9 10589672 (Pubitemid 129746827)
4. Vectors used for expression in mammalian cells. RJ Kaufman, Methods Enzymol 1990 186 487 511 (Pubitemid 20219844)
5. Advances in animal cell recombinant protein production: GS-NSO expression system. LM Barnes,, et al. Cytotechnol 2000 32 109 123 10.1023/A:1008170710003 (Pubitemid 30166226)
6. Production of recombinant protein therapeutics in cultivated mammalian cells. FM Wurm, Nature Biotechnol 2004 22 1393 1398 10.1038/nbt1026 (Pubitemid 39482858)
7. A nuclear DNA attachment element mediates elevated and position-independent gene activity. A Stief DM Winter WH Strätling AE Sippel, Nature 1989 28 343 345 (Pubitemid 20102106)
8. The chicken lysozyme 5' matrix attachment region increases transcription from a heterologous promoter in heterologous cells and dampens position effects on the expression of transfected genes. L Phi-Van JP von Kries W Ostertag WH Strätling, Mol Cell Biol 1990 10 2302 7 2325653
9. Scaffold-attached regions from the human interferon beta domain can be used to enhance the stable expression of genes under the control of various promoters. D Klehr K Maass J Bode, Biochemistry 1991 30 1264 70 10.1021/bi00219a015 1991107
10. Genome-wide prediction of matrix attachment regions that increase gene expression in mammalian cells. PA Girod DQ Nguyen D Calabrese S Puttini M Grandjean D Martinet A Regamey D Saugy JS Beckmann P Bucher N Mermod, Nat Methods 2007 4 747 53 10.1038/nmeth1076 17676049 (Pubitemid 47338170)
11. The use of UCOE vectors in combination with a preadapted serum free, suspension cell line allows for rapid production of large quantities of protein. Benton Chen McEntree Fox King Crombie Thomas Bebbington, Cytotechnology 2002 38 43 46 10.1023/A:1021141712344 19003085
12. Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells. F Zhang SI Thornhill SJ Howe M Ulaganathan A Schambach J Sinclair C Kinnon HB Gaspar M Antoniou AJ Thrasher, Blood 2007 110 1448 57 10.1182/blood-2006-12-060814 17456723 (Pubitemid 47443959)
13. A ubiquitous chromatin opening element (UCOE) confers resistance to DNA methylation-mediated silencing of lentiviral vectors. F Zhang AR Frost MP Blundell O Bales MN Antoniou AJ Thrasher, Mol Ther 2010 18 1640 1649 10.1038/mt.2010.132 20588258
14. Transgenes encompassing dual-promoter CpG islands from the human TBP and HNRPA2B1 loci are resistant to heterochromatin-mediated silencing. M Antoniou L Harland T Mustoe S Williams J Holdstock E Yague T Mulcahy M Griffiths S Edwards PA Ioannou A Mountain R Crombie, Genomics 2003 82 269 279 (Pubitemid 36952300)
15. Correlation of DNA methylation with histone modifications across the HNRPA2B1-CBX3 ubiquitously-acting chromatin open element (UCOE). M Lindahl Allen M Antoniou, Epigenetics 2007 2 227 36 10.4161/epi.2.4.5231 18032920 (Pubitemid 351308298)
16. CpG-island fragments from the HNRPA2B1/CBX3 genomic locus reduce silencing and enhance transgene expression from the hCMV promoter/enhancer in mammalian cells. S Williams T Mustoe T Mulcahy M Griffiths D Simpson M Antoniou A Irvine A Mountain R Crombie, BMC Biotechnol 2005 5 17 10.1186/1472-6750-5-17 15935093